# A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay

> **NCT06731179** · — · ACTIVE_NOT_RECRUITING · sponsor: **ViraxBio Labs** · enrollment: 160 (estimated)

## Conditions studied

- Long COVID
- PTLDs
- Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06731179
- **Lead sponsor:** ViraxBio Labs
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731179, "A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06731179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*